NanoViricides Inchttps://investorshangout.com/NanoViricides-Inc-NNVC-64839/en-usThu, 10 Sep 2026 09:10:15 GMTCopyright InvestorsHangout.comNetworkNewsWire: NetworkNewsBreaks – NanoViricides (NYSE American: NNVC) Registers Phase II Ebola Trial for NV-387https://investorshangout.com/post/view?id=6843730https://investorshangout.com/post/view?id=6843730Tue, 08 Sep 2026 20:19:15 GMTNetworkNewsWire: NetworkNewsBreaks – NanoViricides (NYSE American: NNVC) Announces Approximately $3.8 Million Regihttps://investorshangout.com/post/view?id=6838589https://investorshangout.com/post/view?id=6838589Fri, 24 Jul 2026 20:29:56 GMTNetworkNewsWire: NetworkNewsBreaks – NanoViricides (NYSE American: NNVC) Receives DRC Approval to Advance Proposedhttps://investorshangout.com/post/view?id=6833963https://investorshangout.com/post/view?id=6833963Mon, 15 Jun 2026 22:25:55 GMTNetworkNewsWire: NetworkNewsBreaks – NanoViricides (NYSE American: NNVC) Files Orphan Drug Designation Applicationhttps://investorshangout.com/post/view?id=6815153https://investorshangout.com/post/view?id=6815153Tue, 10 Feb 2026 22:19:47 GMTDavid Pine: Prepare for $NNVC’s explosive growth—future looks bright in biotech. https://www.nanoviricides.https://investorshangout.com/post/view?id=6733407https://investorshangout.com/post/view?id=6733407Wed, 04 Dec 2024 16:30:29 GMTAria: $NNVC's future pipeline holds promise for revolutionizing vaccine technology. https://profiles.smhttps://investorshangout.com/post/view?id=6733406https://investorshangout.com/post/view?id=6733406Wed, 04 Dec 2024 16:26:57 GMTAria: With $NNVC, the future of targeted therapy looks brighter than ever. https://tinyurl.com/y5emzd38 https://investorshangout.com/post/view?id=6733213https://investorshangout.com/post/view?id=6733213Tue, 03 Dec 2024 20:13:54 GMTDavid Pine: $NNVC is set to revolutionize biotech with future breakthrough treatments. https://www.nanoviricihttps://investorshangout.com/post/view?id=6733210https://investorshangout.com/post/view?id=6733210Tue, 03 Dec 2024 20:08:17 GMTDavid Pine: $NNVC is trending—stay ahead of the curve with groundbreaking innovations! https://tinyurl.com/https://investorshangout.com/post/view?id=6733168https://investorshangout.com/post/view?id=6733168Tue, 03 Dec 2024 18:20:29 GMTJack Mallick: NanoViricides, Inc. ($NNVC) is showing strong bullish momentum on the NYSE! With positive news backihttps://investorshangout.com/post/view?id=6733135https://investorshangout.com/post/view?id=6733135Tue, 03 Dec 2024 16:34:21 GMTAria: The future looks bright for $NNVC—strong trends indicate potential growth! https://tinyurl.com/https://investorshangout.com/post/view?id=6733100https://investorshangout.com/post/view?id=6733100Tue, 03 Dec 2024 15:29:43 GMTDavid Pine: $NNVC is leading the fight against viruses with breakthrough technology! https://www.nanovirihttps://investorshangout.com/post/view?id=6732534https://investorshangout.com/post/view?id=6732534Fri, 29 Nov 2024 17:56:21 GMTAria: $NNVC is on the rise—hop on this trending wave today! https://tinyurl.com/2ph6umwnhttps://investorshangout.com/post/view?id=6732532https://investorshangout.com/post/view?id=6732532Fri, 29 Nov 2024 17:48:39 GMTAria: $NNVC is trending high—prepare for their next big breakthrough! https://tinyurl.com/2ph6umwnhttps://investorshangout.com/post/view?id=6732478https://investorshangout.com/post/view?id=6732478Fri, 29 Nov 2024 14:24:13 GMTDavid Pine: $NNVC is trending upward with exciting market potential ahead! https://iotracker12.com/wIlm7 https://investorshangout.com/post/view?id=6732291https://investorshangout.com/post/view?id=6732291Wed, 27 Nov 2024 20:44:09 GMTAria: All eyes on $NNVC—momentum signals promising upward movement! https://profiles.smallcapsdaily.com/https://investorshangout.com/post/view?id=6732289https://investorshangout.com/post/view?id=6732289Wed, 27 Nov 2024 20:41:47 GMTJack Mallick: $NNVC has developed NV-387, a revolutionary broad-spectrum antiviral, to address the urgent need forhttps://investorshangout.com/post/view?id=6732234https://investorshangout.com/post/view?id=6732234Wed, 27 Nov 2024 16:43:38 GMTJack Mallick: $NNVC is on track to launch Phase II trials for NV-387, targeting both RSV and Mpox. These trials aihttps://investorshangout.com/post/view?id=6732094https://investorshangout.com/post/view?id=6732094Tue, 26 Nov 2024 19:57:02 GMTDavid Pine: $NNVC gains 2.57%! NanoViricides continues to show impressive market growth. https://iotracker12https://investorshangout.com/post/view?id=6732081https://investorshangout.com/post/view?id=6732081Tue, 26 Nov 2024 19:06:04 GMTAria: Big energy around $NNVC! The momentum is real—stay tuned! https://profiles.smallcapsdaily.com/nnhttps://investorshangout.com/post/view?id=6732080https://investorshangout.com/post/view?id=6732080Tue, 26 Nov 2024 19:02:17 GMTJack Mallick: $NNVC is catching the market's attention as one of the most valuable stocks right now! With its innhttps://investorshangout.com/post/view?id=6732040https://investorshangout.com/post/view?id=6732040Tue, 26 Nov 2024 16:47:07 GMTDavid Pine: $NNVC’s breakthrough technology positions it as a leader in biotech. https://profiles.smallcapsdahttps://investorshangout.com/post/view?id=6732022https://investorshangout.com/post/view?id=6732022Tue, 26 Nov 2024 16:06:30 GMTAria: Watch $NNVC closely—strong potential and growth on the horizon! https://tinyurl.com/ynvj4x3p https://investorshangout.com/post/view?id=6731989https://investorshangout.com/post/view?id=6731989Tue, 26 Nov 2024 14:05:20 GMTAria: Watch $NNVC break through—solid growth and rising stock value! https://www.nanoviricides.com/https://investorshangout.com/post/view?id=6731836https://investorshangout.com/post/view?id=6731836Mon, 25 Nov 2024 19:07:01 GMTDavid Pine: $NNVC is the stock to watch—market strength driving value! ???? https://iotracker12.com/Oa4no https://investorshangout.com/post/view?id=6731821https://investorshangout.com/post/view?id=6731821Mon, 25 Nov 2024 18:35:25 GMTAria: $NNVC stands out with incredible performance—don’t miss the movement! https://www.nanoviricides.comhttps://investorshangout.com/post/view?id=6731818https://investorshangout.com/post/view?id=6731818Mon, 25 Nov 2024 18:30:57 GMTJack Mallick: The innovative NV-387 targets viral infections like COVID-19, RSV, and influenza, addressing a $2.5–https://investorshangout.com/post/view?id=6731722https://investorshangout.com/post/view?id=6731722Mon, 25 Nov 2024 15:49:33 GMTAria: $NNVC leverages nanoscience for powerful antiviral treatment development. https://www.nanoviricidhttps://investorshangout.com/post/view?id=6731691https://investorshangout.com/post/view?id=6731691Mon, 25 Nov 2024 14:53:32 GMTsmride: SMride is a full-service SEO company NJ that specializhttps://investorshangout.com/post/view?id=6728190https://investorshangout.com/post/view?id=6728190Fri, 08 Nov 2024 08:37:36 GMTNetworkNewsWire: NetworkNewsBreaks – NanoViricides Inc. (NYSE American: NNVC) Announces Filing of Fiscal 2024 Formhttps://investorshangout.com/post/view?id=6721121https://investorshangout.com/post/view?id=6721121Mon, 30 Sep 2024 21:00:29 GMTNetworkNewsWire: NetworkNewsBreaks – NanoViricides Inc. (NYSE American: NNVC) Announces Execution of MoU Agreementhttps://investorshangout.com/post/view?id=6720590https://investorshangout.com/post/view?id=6720590Thu, 26 Sep 2024 20:08:43 GMTwhytestocks: $NNVC News Article - A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox https://investorshangout.com/post/view?id=6691897https://investorshangout.com/post/view?id=6691897Wed, 08 May 2024 14:40:46 GMTms900dumps: What Makes Ms-900 the Best Site for Microsoft MS-900 Test Dumps? Ms-900 offers a PDF organhttps://investorshangout.com/post/view?id=6690083https://investorshangout.com/post/view?id=6690083Thu, 02 May 2024 07:41:55 GMTwhytestocks: $NNVC News Article - NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Succehttps://investorshangout.com/post/view?id=6689565https://investorshangout.com/post/view?id=6689565Tue, 30 Apr 2024 19:10:47 GMTwhytestocks: $NNVC News Article - The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company's Broad-Spectrum https://investorshangout.com/post/view?id=6647626https://investorshangout.com/post/view?id=6647626Tue, 28 Nov 2023 17:15:48 GMTwhytestocks: $NNVC News Article - Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,0https://investorshangout.com/post/view?id=6623142https://investorshangout.com/post/view?id=6623142Wed, 27 Sep 2023 19:00:52 GMTwhytestocks: $NNVC News Article - The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company's Broad-Spectrum https://investorshangout.com/post/view?id=6610364https://investorshangout.com/post/view?id=6610364Mon, 21 Aug 2023 14:55:45 GMTwhytestocks: $NNVC News Article - NanoViricides testing oral gummy and syrup Covid-19 treatment - Proactive Reseahttps://investorshangout.com/post/view?id=6595690https://investorshangout.com/post/view?id=6595690Thu, 13 Jul 2023 12:40:45 GMTwhytestocks: $NNVC News Article - Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials https://investorshangout.com/post/view?id=6594874https://investorshangout.com/post/view?id=6594874Tue, 11 Jul 2023 14:35:47 GMTwhytestocks: $NNVC News Article - NanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoVhttps://investorshangout.com/post/view?id=6562044https://investorshangout.com/post/view?id=6562044Mon, 17 Apr 2023 14:10:49 GMTwhytestocks: $NNVC News Article - NanoViricides Signs a License Agreement That Includes Clinical Evaluation of Ithttps://investorshangout.com/post/view?id=6556564https://investorshangout.com/post/view?id=6556564Tue, 04 Apr 2023 14:40:46 GMTwhytestocks: $NNVC News Article - NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in Shttps://investorshangout.com/post/view?id=6518228https://investorshangout.com/post/view?id=6518228Wed, 04 Jan 2023 13:00:45 GMTwhytestocks: $NNVC News Article - NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug NV-CoV-2 IND https://investorshangout.com/post/view?id=6485178https://investorshangout.com/post/view?id=6485178Fri, 14 Oct 2022 16:05:48 GMTznewcar1: NNVC 40% v1,3M c2.60 f11,534M H2.67 EODhttps://investorshangout.com/post/view?id=6407537https://investorshangout.com/post/view?id=6407537Fri, 20 May 2022 23:06:28 GMTwhytestocks: $NNVC News Article - NanoViricides Reports that It Has Begun Drug Development to Combat Recent Caseshttps://investorshangout.com/post/view?id=6403794https://investorshangout.com/post/view?id=6403794Mon, 16 May 2022 14:25:48 GMTwhytestocks: $NNVC News Article - NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program Rapidhttps://investorshangout.com/post/view?id=6261875https://investorshangout.com/post/view?id=6261875Wed, 13 Oct 2021 18:11:05 GMTwhytestocks: $NNVC News Article - Rapid Advancements of Innovative Antiviral - COVID-19 Drugs Generating Major Grhttps://investorshangout.com/post/view?id=6259622https://investorshangout.com/post/view?id=6259622Mon, 11 Oct 2021 14:45:50 GMTwhytestocks: $NNVC News Article - NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effectivehttps://investorshangout.com/post/view?id=6259602https://investorshangout.com/post/view?id=6259602Mon, 11 Oct 2021 14:30:49 GMTwhytestocks: $NNVC News Article - NanoViricides, Inc. Invites You to Join Us at the Benzinga Healthcare Small Caphttps://investorshangout.com/post/view?id=6249787https://investorshangout.com/post/view?id=6249787Mon, 27 Sep 2021 15:25:49 GMTwhytestocks: $NNVC News Article - Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Duehttps://investorshangout.com/post/view?id=6245990https://investorshangout.com/post/view?id=6245990Wed, 22 Sep 2021 12:00:50 GMT